First-in-man Phase I trial of BYK408740, an oral histone deacetylase inhibitor, in patients with advanced malignancies

被引：0
|
作者：
Ang, J. E. [1 ]
Hauns, B. [2 ]
Mais, A. [2 ]
Parker, A. [1 ]
Lal, R. [1 ]
Olmos, D. [1 ]
Mollenhauer, M. [2 ]
Walz, A. [2 ]
de Bono, J. S. [1 ]
机构：
[1] Royal Marsden Hosp, Drug Dev Unit, Sutton, Surrey, England
[2] Nycomed GmbH, Exploratory Clin Dev, Constance, Germany
来源：
EJC SUPPLEMENTS | 2008年 / 6卷 / 12期
关键词：
D O I：
10.1016/S1359-6349(08)72327-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：123 / 124
页数：2
相关论文
共 50 条
  • [1] Phase I Study of the Oral Histone Deacetylase Inhibitor SB939 In Patients with Advanced Hematologic Malignancies
    Garcia-Manero, Guillermo
    Chuah, Charles
    Wilding, George
    Chang, Julie
    Verstovsek, Srdan
    Faderl, Stefan
    Kantarjian, Hagop M.
    Ethirajulu, Kantharaj
    Zhu, Joy
    BLOOD, 2010, 116 (21) : 1349 - 1349
  • [2] First-in-Man Phase I Trial of the Selective MET Inhibitor Tepotinib in Patients with Advanced Solid Tumors
    Falchook, Gerald S.
    Kurzrock, Razelle
    Amin, Hesham M.
    Xiong, Wenyuan
    Fu, Siqing
    Piha-Paul, Sarina A.
    Janku, Filip
    Eskandari, Ghazaleh
    Catenacci, Daniel V.
    Klevesath, Manfred
    Bruns, Rolf
    Stammberger, Uz
    Johne, Andreas
    Bladt, Friedhelm
    Friese-Hamim, Manja
    Girard, Pascal
    El Bawab, Samer
    Hong, David S.
    CLINICAL CANCER RESEARCH, 2020, 26 (06) : 1237 - 1246
  • [3] Preliminary Results of An Ongoing Phase I Trial of Oral Belinostat a Novel Histone Deacetylase Inhibitor in Patients with Lymphoid Malignancies
    Zain, Jasmine M.
    Foss, Francine M.
    Diefenbach, Catherine S.
    Petrylak, Daniel
    Narwal, Ameet
    Neylon, Ellen
    Knoblauch, Poul
    O'Connor, Owen A.
    BLOOD, 2011, 118 (21) : 1585 - 1585
  • [4] A phase I clinical trial of the histone deacetylase inhibitor belinostat in patients with advanced hematological neoplasia
    Gimsing, Peter
    Hansen, Mads
    Knudsen, Lene M.
    Knoblauch, P.
    Christensen, Ib Jarle
    Ooi, Chean Eng
    Buhl-Jensen, Peter
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2008, 81 (03) : 170 - 176
  • [5] Interim Results of a Phase 1 Trial of An Oral Histone Deacetylase Inhibitor Belinostat In Patients with Lymphoid Malignancies.
    Zain, Jasmine M.
    Foss, Francine M.
    de Bono, Johann S.
    Narwal, Ameet
    Neylon, Ellen
    Blumenschein, George
    Lassen, U.
    Knoblauch, Poul
    Diefenbach, Catherine S.
    O'Connor, Owen A.
    BLOOD, 2010, 116 (21) : 745 - 746
  • [6] A phase I first-in-human study with tefinostat - a monocyte/macrophage targeted histone deacetylase inhibitor - in patients with advanced haematological malignancies
    Ossenkoppele, Gert J.
    Lowenberg, Bob
    Zachee, Pierre
    Vey, Norbert
    Breems, Dimitri
    Van de Loosdrecht, Arjan A.
    Davidson, Alan H.
    Wells, Graham
    Needham, Lindsey
    Bawden, Lindsay
    Toal, Martin
    Hooftman, Leon
    Debnam, Phillip M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 162 (02) : 191 - 201
  • [7] Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer
    Kelly, WK
    O'Connor, OA
    Krug, LM
    Chiao, JH
    Heaney, M
    Curley, T
    MacGregore-Cortelli, B
    Tong, W
    Secrist, JP
    Schwartz, L
    Richardson, S
    Chu, E
    Olgac, S
    Marks, PA
    Scher, H
    Richon, VM
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (17) : 3923 - 3931
  • [8] CHR-2845, a Monocyte/Macrophage Targeted Histone Deacetylase Inhibitor In a First In Man Clinical Trial In Subjects with Advanced Haematological Malignancies
    Ossenkoppele, Gert
    Lowenberg, Bob
    Zachee, Pierre
    Vey, Norbert
    Breems, Dimitri
    Van de Loosdrecht, Arjan A.
    Debnam, Phillip
    Needham, Lindsey
    Bawden, Lindsay
    Hooftman, Leon
    BLOOD, 2010, 116 (21) : 1344 - 1344
  • [9] Phase I trial of the histone deacetylase inhibitor valproic acid with the topoisomerase I inhibitor, karenitecin in advanced melanoma
    Daud, A.
    Gump, J. L.
    Neuger, A.
    DeConti, R. H.
    Bastien, S.
    Mintz, M.
    Hausheer, F. H.
    Lush, R.
    Sullivan, D. M.
    Munster, P. N.
    EJC SUPPLEMENTS, 2006, 4 (12): : 92 - 92
  • [10] First-in-human, Pharmacokinetic and Pharmacodynamic Phase I Study of Resminostat, an Oral Histone Deacetylase Inhibitor, in Patients with Advanced Solid Tumors
    Brunetto, Andre T.
    Ang, Joo Ern
    Lal, Rohit
    Olmos, David
    Molife, L. Rhoda
    Kristeleit, Rebecca
    Parker, Ann
    Casamayor, Isabel
    Olaleye, Muyibat
    Mais, Anna
    Hauns, Bernhard
    Strobel, Vera
    Hentsch, Bernd
    de Bono, Johann S.
    CLINICAL CANCER RESEARCH, 2013, 19 (19) : 5494 - 5504
12345